Literature DB >> 7678300

Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells.

B Caughey1, G J Raymond.   

Abstract

The accumulation of an abnormal, protease-resistant form of the protein PrP (PrP-res) in hosts with scrapie and related transmissible spongiform encephalopathies appears to be important in disease pathogenesis. To gain insight into the mechanism of PrP-res accumulation and the in vivo antiscrapie activity of certain polyanions, we have studied effects of sulfated glycans on PrP metabolism in scrapie-infected neuroblastoma cells. Pentosan polysulfate, like the amyloid-binding dye Congo red, potently inhibited the accumulation of PrP-res in these cells without apparent effects on the metabolism of the normal isoform. The inhibition was due primarily to prevention of new PrP-res accumulation rather than destabilization of preexisting PrP-res. PrP-res accumulation remained depressed in the cultures after removal of the inhibitors. The activities of other sulfated glycans, nonsulfated polyanions, dextran, and DEAE-dextran were compared with those of pentosan polysulfate and Congo red. This comparison provided evidence that the density of sulfation and molecular size are factors influencing anti-PrP-res activity of sulfated glycans. The relative potencies of these compounds corresponded well with their previously determined antiscrapie activities in vivo, suggesting that the prophylactic effects of sulfated polyanions may be due to inhibition of PrP-res accumulation. Since PrP-res amyloid is known to contain sulfated glycosaminoglycans, we reason that these inhibitors may competitively block an interaction between PrP and endogenous glycosaminoglycans that is essential for its accumulation in a protease-resistant, potentially amyloidogenic state.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678300      PMCID: PMC237415     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  INHIBITION OF HERPES VIRUS BY NATURAL AND SYNTHETIC ACID POLYSACCHARIDES.

Authors:  K K TAKEMOTO; P FABISCH
Journal:  Proc Soc Exp Biol Med       Date:  1964-05

Review 2.  The scrapie agent: "a virus by any other name".

Authors:  R G Rohwer
Journal:  Curr Top Microbiol Immunol       Date:  1991       Impact factor: 4.291

3.  Action of dextran sulfate as a direct and general B cell mitogen.

Authors:  R Dörries; A Schimpl; E Wecker
Journal:  Eur J Immunol       Date:  1974-03       Impact factor: 5.532

4.  Stimulation of DNA synthesis in mouse lymphoid cells by polyanions in vitro. II. Relationship between adjuvant activity and stimulation of DNA synthesis by polyanions.

Authors:  W Vogt; H Rühl; B Wagner; T Diamantstein
Journal:  Eur J Immunol       Date:  1973-08       Impact factor: 5.532

Review 5.  From arthritis to Alzheimer's disease: current concepts on the pathogenesis of amyloidosis.

Authors:  R Kisilevsky
Journal:  Can J Physiol Pharmacol       Date:  1987-09       Impact factor: 2.273

6.  Interference with normal phagosome-lysosome fusion in macrophages, using ingested yeast cells and suramin.

Authors:  P D Hart; M R Young
Journal:  Nature       Date:  1975-07-03       Impact factor: 49.962

7.  Stimulation of humoral antibody formation by polyanions. II. The influence of sulfate esters of polymers on the immune response in mice.

Authors:  T Diamantstein; B Wagner; I Beyse; M V Odenwald; G Schulz
Journal:  Eur J Immunol       Date:  1971-11       Impact factor: 5.532

8.  Potent inhibition of scrapie-associated PrP accumulation by congo red.

Authors:  B Caughey; R E Race
Journal:  J Neurochem       Date:  1992-08       Impact factor: 5.372

9.  X-ray diffraction studies of polysaccharide sulphates: double helix models for k- and l-carrageenans.

Authors:  N S Anderson; J W Campbell; M M Harding; D A Rees; J W Samuel
Journal:  J Mol Biol       Date:  1969-10-14       Impact factor: 5.469

10.  Sulphate polyanions prolong the incubation period of scrapie-infected hamsters.

Authors:  A Ladogana; P Casaccia; L Ingrosso; M Cibati; M Salvatore; Y G Xi; C Masullo; M Pocchiari
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

View more
  136 in total

1.  Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.

Authors:  C Wong; L W Xiong; M Horiuchi; L Raymond; K Wehrly; B Chesebro; B Caughey
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

2.  Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.

Authors:  K Doh-Ura; T Iwaki; B Caughey
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update.

Authors:  B Caughey; G J Raymond; S A Priola; D A Kocisko; R E Race; R A Bessen; P T Lansbury; B Chesebro
Journal:  Mol Biotechnol       Date:  1999-11       Impact factor: 2.695

4.  Scrapie strains maintain biological phenotypes on propagation in a cell line in culture.

Authors:  C R Birkett; R M Hennion; D A Bembridge; M C Clarke; A Chree; M E Bruce; C J Bostock
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

5.  Abrogation of complex glycosylation by swainsonine results in strain- and cell-specific inhibition of prion replication.

Authors:  Shawn Browning; Christopher A Baker; Emery Smith; Sukhvir P Mahal; Maria E Herva; Cheryl A Demczyk; Jiali Li; Charles Weissmann
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

6.  Development of in vitro cell cultures for the evaluation of molecules with antiprionic activity.

Authors:  C Pollera; G Carcassola; W Ponti; G Poli
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

7.  Development of in vitro cell cultures for the evaluation of molecules with antiprionic activity.

Authors:  C Pollera; G Carcassola; W Ponti; G Poli
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

8.  Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists.

Authors:  Erik C Gunther; Levi M Smith; Mikhail A Kostylev; Timothy O Cox; Adam C Kaufman; Suho Lee; Ewa Folta-Stogniew; George D Maynard; Ji Won Um; Massimiliano Stagi; Jacqueline K Heiss; Austin Stoner; Geoff P Noble; Hideyuki Takahashi; Laura T Haas; John S Schneekloth; Janie Merkel; Christopher Teran; Zahra K Naderi; Surachai Supattapone; Stephen M Strittmatter
Journal:  Cell Rep       Date:  2019-01-02       Impact factor: 9.423

9.  New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products.

Authors:  David A Kocisko; Gerald S Baron; Richard Rubenstein; Jiancao Chen; Salomon Kuizon; Byron Caughey
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus α-synuclein and β-amyloid aggregates.

Authors:  Barbara E Stopschinski; Brandon B Holmes; Gregory M Miller; Victor A Manon; Jaime Vaquer-Alicea; William L Prueitt; Linda C Hsieh-Wilson; Marc I Diamond
Journal:  J Biol Chem       Date:  2018-05-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.